410
Views
77
CrossRef citations to date
0
Altmetric
Review

Autoimmune atrophic gastritis: current perspectives

, , , &
Pages 19-27 | Published online: 07 Feb 2017

References

  • AndresESerrajKOptimal management of pernicious anemiaJ Blood Med201239710323028239
  • ParkJYLam-HimlinDVemulapalliRReview of autoimmune meta-plastic atrophic gastritisGastrointest Endosc201377228429223199649
  • CarmelRJohnsonCSRacial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black womenN Engl J Med197829812647650628388
  • Lam-TseWKBatstraMRKoelemanBPThe association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetesPediatr Endocrinol Rev200311223716437010
  • NeumannWLCossERuggeMGentaRMAutoimmune atrophic gastritis – pathogenesis, pathology and managementNat Rev Gastroenterol Hepatol201310952954123774773
  • SilveiraPAWilsonWEEstebanLMIdentification of the Gasa3 and Gasa4 autoimmune gastritis susceptibility genes using congenic mice and partitioned, segregative and interaction analysesImmunogenetics200153974175011862406
  • BaxterAGJordanMASilveiraPAWilsonWEVan DrielIRGenetic control of susceptibility to autoimmune gastritisInt Rev Immunol2005241–2556215763989
  • IkedaTSenoueIHaraMTsutsumiYHarasawaSMiwaTGastric pseudopolyposis: a new clinical manifestation of type A gastritisAm J Gastroenterol198580282903970005
  • KrasinskasAMAbrahamSCMetzDCFurthEEOxyntic mucosa pseudopolyps: a presentation of atrophic autoimmune gastritisAm J Surg Pathol200327223624112548171
  • JuddLMGleesonPATohBHvan DrielIRAutoimmune gastritis results in disruption of gastric epithelial cell developmentAm J Physiol19992771 pt 1G209G21810409169
  • ChlumskaABoudovaLBenesZZamecnikMAutoimmune gastritis. A clinicopathologic study of 25 casesCesk Patol200541413714216382988
  • StolteMBethkeBRuhlGRitterMOmeprazole-induced pseudohypertrophy of gastric parietal cellsZ Gastroenterol19923021341381553828
  • SolciaEFioccaRVillaniLLuinettiOCapellaCHyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesisAm J Surg Pathol199519Suppl 1S1S77762735
  • LiPHeCSunLDongNYuanYPepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous diseaseBMC Clin Pathol201313111023360534
  • GoldenringJRRayGSCoffeyRJJrReversible drug-induced oxyntic atrophy in ratsGastroenterology200011861080109310833483
  • NomuraSYamaguchiHOgawaMWangTCLeeJRGoldenringJRAlterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient miceAm J Physiol Gastrointest Liver Physiol20052882G362G37515647607
  • NozakiKOgawaMWilliamsJAA molecular signature of gastric metaplasia arising in response to acute parietal cell lossGastroenterology2008134251152218242217
  • WeisVGPetersenCPMillsJCTumaPLWhiteheadRHGoldenringJREstablishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomachAm J Physiol Gastrointest Liver Physiol20143078G777G79225190476
  • HalldorsdottirAMSigurdardottrirMJonassonJGSpasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in IcelandDig Dis Sci200348343144112757153
  • GoldenringJRNamKTWangTCMillsJCWrightNASpasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancerGastroenterology20101387220722102210.e120450866
  • CorreaPPiazueloMBWilsonKTPathology of gastric intestinal metaplasia: clinical implicationsAm J Gastroenterol2010105349349820203636
  • AbrahamSCSinghVKYardleyJHWuTTHyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophyAm J Surg Pathol200125450050711257625
  • VeijolaLIOksanenAMSipponenPIRautelinHIKAssociation of autoimmune type atrophic corpus gastritis with Helicobacter pylori infectionWorld J Gastroenterol2010161838820039453
  • NegriniRSavioAPoiesiCAntigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritisGastroenterology199611136556658780570
  • FallerGSteiningerHEckMHensenJHannEGKirchnerTAnti-gastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevanceVirchows Arch199642754834868624577
  • GentaRMHelicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophyGastroenterology19971136 supplS51S559394760
  • TorbensonMAbrahamSCBoitnottJYardleyJHWuTTAutoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glandsMod Pathol200215210210911850538
  • De ReVOrzesECanzonieriVPepsinogens to distinguish patients with gastric intestinal metaplasia and Helicobacter pylori infection among populations at risk for gastric cancerClin Transl Gastroenterol201677e18327441820
  • CastoroCLe MoliRArpiMLAssociation of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institutionJ Endocrinol Invest201639777978426928404
  • CentanniMMarignaniMGarganoLAtrophic body gastritis in patients with autoimmune thyroid disease: an under diagnosed associationArch Intern Med1999159151726173010448775
  • De BlockCEDe LeeuwIHVan GaalLFAutoimmune gastritis in type 1 diabetes: a clinically oriented reviewJ Clin Endocrinol Metab200893236337118029461
  • Ness-AbramofRNabriskiDABravermanLEPrevalence and evaluation of B12 deficiency in patients with autoimmune thyroid diseaseAm J Med Sci2006332311912216969140
  • AmerioPTracannaMDe RemigisPVitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4Clin Exp Dermatol200631574674916803462
  • ZelissenPMBastEJCroughsRJAssociated autoimmunity in Addison’s diseaseJ Autoimmun1995811211307734032
  • ChangKHLyuRKRoLSWuYRChenCMCoexistence of pernicious anemia and myasthenia gravis – a rare combination of autoimmune diseases in TaiwanJ Formos Med Assoc20061051194694917098697
  • DelvaPLMacDonellJEMacIntoshOCMegaloblastic anemia occurring simultaneously in white female monozygotic twinsCan Med Assoc J196592211129113114285300
  • BankaSRyanKThomsonWNewmanWGPernicious anemia – genetic insightsAutoimmun Rev201110845545921296191
  • BonafouxBHenryLDelfourCAssociation of familial pernicious anaemia and hereditary haemochromatosisActa Haematol20081191121418176074
  • RusakEChobotAKrzywickaAWenzlauJAnti-parietal cell antibodies – diagnostic significanceAdv Med Sci201661217517926918709
  • KhanSDel-DucaCFentonELimited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemiaJ Clin Pathol200962543944119398595
  • OttesenMFeldt-RasmussenUFAndersenJHippeESchouboeAPernicious anemia. A study of initial forms of the disease and diagnostic significance of determination of the intrinsic factor antibody and parietal cell antibodyUgeskr Laeger199215452375837621471305
  • AnticoATampoiaMVillaltaDTonuttiETozzoliRBizzaroNClinical usefulness of the serological gastric biopsy for the diagnosis of chronic autoimmune gastritisClin Dev Immunol2012201252097023251219
  • ShahPSinghMHYangYXMetzDCHypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for Zollinger-Ellison syndromePancreas201342693223851430
  • PhanJBenhammouJNPisegnaJRGastric hypersecretory states: investigation and managementCurr Treat Options Gastroenterol201513438639726342486
  • CarmelRPepsinogens and other serum markers in pernicious anemiaAm J Clin Pathol19889044424453177265
  • WainwrightPNarayananSCookPFalse-normal vitamin B12 results in a patient with pernicious anaemiaClin Biochem201548181366136726277634
  • SolomonLRCobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testingBlood2005105397898515466926
  • WuPBDengYZShuYXTanSYLiMFangGIncreased plasma CgA levels associated with nonalcoholic fatty liver diseaseTurk J Gastroenterol201526540440726215060
  • PeracchiMGebbiaCBasiliscoGPlasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoidsEur J Endocrinol2005152344344815757862
  • MassironiSFraquelliMPaggiSChromogranin A levels in chronic liver disease and hepatocellular carcinomaDig Liver Dis2009411313518762462
  • ParkYHKimNReview of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancerJ Cancer Prev2015201254025853101
  • DaiY-CTangZ-PZhangY-LHow to assess the severity of atrophic gastritisWorld J Gastroenterol201117131690169321483628
  • AnagnostopoulosGKRagunathKShondeAHawkeyCJYaoKDiagnosis of autoimmune gastritis by high resolution magnification endoscopyWorld J Gastroenterol200612284586458716874879
  • NomuraSIdaKTeraoSEndoscopic diagnosis of gastric mucosal atrophy: multicenter prospective studyDig Endosc201426670971924698334
  • DixonMFGentaRMYardleyJHCorreaPClassification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994Am J Surg Pathol19962010116111818827022
  • WongHHChuPImmunohistochemical features of the gastrointestinal tract tumorsJ Gastrointest Oncol20123326228422943017
  • SepulvedaARPatilMPractical approach to the pathologic diagnosis of gastritisArch Pathol Lab Med2008132101586159318834216
  • SmithADMMegaloblastic madnessBr Med J1960252161840184520789014
  • HershkoCHoffbrandAKeretDRole of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemiaHaematologica200590558559515921373
  • GonçalvesCOliveiraMEPalhaAMFerrãoAMoraisALopesAIAutoimmune gastritis presenting as iron deficiency anemia in childhoodWorld J Gastroenterol20142042157801578625400463
  • MiguelNCostaESantalhaMJrRefractory iron-deficiency anemia and autoimmune atrophic gastritis in pediatric age group: analysis of 8 clinical casesJ Pediatr Hematol Oncol201436213413924327126
  • StablerSPClinical practice. Vitamin B12 deficiencyN Engl J Med2013368214916023301732
  • TefferiAPruthiRKThe biochemical basis of cobalamin deficiencyMayo Clin Proceed1994692181186
  • AsimacopoulosPJGrovesMDFischerDKPernicious anemia manifesting as angina pectorisSouth Med J19948766716728202783
  • TadakamallaAKTalluriSKBesurSPseudo-thrombotic thrombocytopenic purpura: a rare presentation of pernicious anemiaN Am J Med Sci201131047247422363087
  • MelhemADesaiAHofmannMAAcute myocardial infarction and pulmonary embolism in a young man with pernicious anemia-induced severe hyperhomocysteinemiaThromb J2009711519232081
  • ShamkaniWAJafarNSNarayananSRRajappanAKAcute myocardial infarction in a young lady due to vitamin B12 deficiency induced hyperhomocysteinemiaHeart Views2015161252925838876
  • MetzJCobalamin deficiency and the pathogenesis of nervous system diseaseAnnu Rev Nutr19921259791354465
  • FrancisGHoholKJawadZAyerATothCMethylmalonic acid accumulation and the development of peripheral neuropathy (IN1-1.010)Neurology2012781 supplIN1IN1
  • RalapanawaDMJayawickremeKPEkanayakeEMJayalathWAB(12) deficiency with neurological manifestations in the absence of anaemiaBMC Res Notes2015845826385097
  • LindenbaumJHealtonEBSavageDGNeuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosisN Engl J Med198831826172017283374544
  • HemmerBGlockerFXSchumacherMDeuschlGLückingCHSubacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findingsJ Neurol Neurosurg Psychiatry19986568228279854956
  • VasconcelosOMPoehmEHMcCarterRJCampbellWWQuezadoZMNPotential outcome factors in subacute combined degeneration: review of observational studiesJ Gen Intern Med200621101063106816970556
  • SapersteinDSBarohnRJPeripheral neuropathy due to cobalamin deficiencyCurr Treat Options Neurol20024319720111931726
  • ChuCScanlonPVitamin B12 deficiency optic neuropathy detected by asymptomatic screeningBMJ Case Rep20112011 bcr0220113823
  • MetzlerDMillerWHStephen EdwardsCPsychiatric manifestation of vitamin B-12 deficiency: an updateJefferson J Psychiatry199192
  • DouaudGRefsumHde JagerCAPreventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatmentProc Natl Acad Sci U S A2013110239523952823690582
  • LahnerEAnnibaleBPernicious anemia: new insights from a gastroenterological point of viewWorld J Gastroenterol200915415121512819891010
  • ZhuJCWangYFShengJChenFXTangGYAtrophic glossitis is attributed to cobalamin deficiencyShanghai J Stomatol20132215862
  • VannellaLLahnerEOsbornJAnnibaleBSystematic review: gastric cancer incidence in pernicious anaemiaAliment Pharmacol Ther201337437538223216458
  • VannellaLSbrozzi-VanniALahnerEDevelopment of type I gastric carcinoid in patients with chronic atrophic gastritisAliment Pharmacol Ther201133121361136921492197
  • LahnerEEspositoGGalliGAnnibaleBAtrophic gastritis and pre-malignant gastric lesionsTransl Gastrointest Cancer201544272281
  • SchnellerJGuptaRMustafaJVillanuevaRStrausEWRaffanielloRDHelicobacter pylori infection is associated with a high incidence of intestinal metaplasia in the gastric mucosa of patients at inner-city hospitals in New YorkDig Dis Sci200651101801180916944298
  • WongBCLamSKWongWMChina Gastric Cancer Study GroupHelicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trialJAMA2004291218719414722144
  • CorreaPPiazueloMBThe gastric precancerous cascadeJ Dig Dis20121312922188910
  • YongXTangBLiB-SHelicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathwaysCell Commun Signal201513111325589173
  • YamaokaYMechanisms of disease: Helicobacter pylori virulence factorsNat Rev Gastroenterol Hepatol201071162964120938460
  • van DoornLJFigueiredoCSannaRClinical relevance of the cagA, vacA, and iceA status of Helicobacter pyloriGastroenterology1998115158669649459
  • WroblewskiLEPeekRMWilsonKTHelicobacter pylori and gastric cancer: factors that modulate disease riskClin Microbiol Rev201023471373920930071
  • ZhouKHoWGastric carcinoids: classification and DiagnosisPisegnaRJManagement of Pancreatic Neuroendocrine TumorsNew York, NYSpringer New York20158393
  • BurkittMDPritchardDMReview article: pathogenesis and management of gastric carcinoid tumoursAliment Pharmacol Ther20062491305132017059512
  • LiT-TQiuFQianZRWanJQiX-KWuB-YClassification, clinicopathologic features and treatment of gastric neuroendocrine tumorsWorld J Gastroenterol201420111812524415864
  • AndresEFothergillHMeciliMEfficacy of oral cobalamin (vitamin B12) therapyExpert Opin Pharmacother201011224925620088746
  • StolteMMeierEMeiningACure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old maleZ Gastroenterol19983686416439773482
  • FallerGWinterMSteiningerHDecrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infectionPathol Res Pract1999195424324610337662
  • NikouGCAngelopoulosTPCurrent concepts on gastric carcinoid tumorsGastroenterol Res Pract2012201228782523316222
  • DockrayGJClinical endocrinology and metabolism. GastrinBest Pract Res Clin Endocrinol Metab200418455556815533775
  • MooreARBoyceMSteeleIACampbellFVarroAPritchardDMNetazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritisPLoS One2013810e7646224098507
  • FossmarkRSordalOJianuCSTreatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin AAliment Pharmacol Ther20123611–121067107523072686
  • MassironiSZilliAFanettiICiafardiniCConteDPeracchiMIntermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritisDig Liver Dis2015471197898326321479
  • KwekkeboomDJKrenningEPPeptide receptor radionuclide therapy in the treatment of neuroendocrine tumorsHematol Oncol Clin North Am201630117919126614376